Compare · 2 funds side by side · dividends reinvested

GNOM and IBB

GNOMGlobal X×IBBiShares×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$14,214IBB · best of the two

02 / 04

GNOM and IBB, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Global X - Genomics & Biotechnology ETFSectors · Technology0.50%0.93%+54.5%+62.1%+26.0%−3.6%−18.2%33.5%$110M1.5

iShares Biotechnology ETFSectors · Technology0.44%0.15%+31.1%+40.7%+25.4%+7.3%−9.6%22.8%$11.4B1.5

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 4, 2026 · returns include dividends · since: GNOM 2019 · IBB 2001

Head to Head

Swap sides Versus in desk

Head to Head

Global X - Genomics & Biotechnology ETF · $110M$8,342

GNOM

IBB

iShares Biotechnology ETF · $11.4B$14,214

$10,000 five years ago, dividends reinvested · they hold 24.1% in common

GNOMMeasureIBB

+54.5%Year to dateJan 1 → Nov 4+31.1%

+62.1%1 yearTotal return+40.7%

+26.0%3 years · per year$10,000 became $20,023 · $19,707+25.4%

−3.6%5 years · per year$10,000 became $8,342 · $14,214+7.3%

0.50%Expense ratio$50 · $44 a year on $10k · lower is better0.44%

0.93%Trailing 12-mo yield$93 · $15 a year on $10k0.15%

−18.2%Worst dropSmaller is better−9.6%

33.5%VolatilityLower is calmer22.8%

GNOMIBB Winner of the row, in its colourEach row: the bigger of the two fills its side

4–4Level

End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

GNOM vs IBB: Top 5 Holdings

Today

GNOM

33.9%in top 5

IBB

in top 537.0%

GNOMStockIBB

11.6%MRNA5.7%

not top 5GILD8.9%

not top 5AMGN8.3%

not top 5VRTX7.5%

not top 5REGN6.6%

6.1%TWSTnot top 5

5.5%GHnot top 5

5.4%TXGnot top 5

5.3%NTRAnot top 5

Held in common24.1%

End-of-day Nov 4, 2026 · share of each fund

GNOM vs IBB Returns, Every Period

Global XGNOM

−3.6%

5 years, per year

IBBiShares

+7.3%

5 years, per year

GNOMIBBFaded: behind in that period

3–1GNOM wins

End-of-day Nov 4, 2026 · dividends in · faded = behind in that period

GNOM vs IBB

YTD

Global XGNOM

+54.5%

IBBiShares

+31.1%

+54.5%Year to date+31.1%

−18.2%Worst drop · 1Y−9.6%

33.5%Volatility · 1Y22.8%

0.9%Yield0.2%

$110MAssets$11.4B

2–2level

End-of-day Nov 4, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: GNOM, IBB

Today

0.44%lowest, IBB

FundExpense ratioFee$10k

IBB0.44%$44

GNOM0.50%$50

End-of-day Nov 4, 2026 · fee on $10,000 a year

Yields: GNOM, IBB

0.93%highest, GNOM

FundTrailing yieldYield$10k

GNOM0.93%$93

IBB0.15%$15

End-of-day Nov 4, 2026 · trailing 12-month yield

Income After Fees on $10,000

$43most kept, GNOM

GNOM$93 − $50 = $43

IBB$15 − $44 = −$29

KeptFee

End-of-day Nov 4, 2026 · yield in dollars minus the fee

Overlap: GNOM, IBB

Today

24.1%most shared, GNOM and IBB

GNOMIBB

GNOM—24.1%

IBB24.1%—

End-of-day Nov 4, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+62.1%GNOM, at 33.5% volatility

IBBWorst drop−9.6%22.8% vol

GNOMWorst drop−18.2%33.5% vol

End-of-day Nov 4, 2026 · up and left is better

Paid More vs Made More

YTD

GNOMIBB

+54.5%Year to date+31.1%

0.9%Yield0.2%

+62.1%Past year+40.7%

0.50%Fee0.44%

3–1GNOM wins

End-of-day Nov 4, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+35.3%

VIGVanguard

+16.4%

+35.3%Year to date+16.4%

2.9%Yield1.4%

$123BAssets$109B

2–0SCHD wins

End-of-day Nov 4, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+8.8%

+8.5%Year to date+8.8%

12.2%Yield7.8%

$42.1BAssets$46.1B

1–1level

End-of-day Nov 4, 2026

SPYM vs SPY

YTD

SPDRSPYM

+13.4%

SPYSPDR

+13.3%

+13.4%Year to date+13.3%

1.0%Yield1.0%

$182BAssets$805B

1–0SPYM wins

End-of-day Nov 4, 2026